Please assess the completion status of the following clinical trial:

Trial Title: Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* colorectal metastatic adenocarcinoma (stage IV) with unresectables, measurables and visibles secondary lesions~* primitive tumor must be operate~* patient age between 18 and 70~* OMS status performance \< 2~* life expectancy \> 12 weeks~* hematologic function : PNN \>/= 1.5x10\^9/L, platelets \>/= 100x10\^9/L~* hepatic function : bilirubin \</= 1.5xLSN, AST and ALT \</= 3xLSN, alcalin phosphatasis \</= 3xLSN~* plasmatimic creatin \</= 1.25xLSN~* No previous chemotherapy or pelvic radiotherapy~* men and women in age of procreate agreeing to use a contraception until 4 months after the end of treatment for women and until 6 months for men~Exclusion Criteria:~* nonmetastatic forms~* Colorectal tumor which requires preoperative radiotherapy~* nonmeasurable metastasis based on RECIST criteria~* previous chemotherapy for colorectal cancer~* previous irradiation of the primitive tumour~* specific indication against the treatment studied~* Patient considered as inoperable for physiological or carcinologic reasons~* Pregnant or breast feeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- FOLFOX + surgery + FOLFOX (Type: EXPERIMENTAL): * Systemic chemotherapy (modified FOLFOX 4) 48 hours before surgery~* resection of the colorectal tumor during surgery~* Resumption of FOLFOX within the month after surgery (post operative administration of 4 course of treatment and assessment of the response)

Based on this trial design, predict the completion outcome and termination type (if applicable).